|
|||
|
|
The goal of tumor surgery anywhere in the body is to "get the cancer out." When a surgeon excises a tumor from an organ like the breast, lung, kidney, or skin, the risk of recurrence is reduced by intentionally taking out "a margin of good tissue." With brain tumors, this is not an option. Removing a margin of good brain tissue could result in severe neurological deficits with unacceptable reductions in quality of life. Volumetric stereotactic technology is the best available tool for enabling a surgeon to "see" the all-important but elusive boundary between a tumor and a patient's brain. Seeing the Unseeable Radiographic and magnetic images
are converted into a detailed 3-dimensional model of an individual patient's
brain, by using a unique computer application called COMPASS,
developed by Dr. Kelly and his colleagues. During surgery," Dr. Kelly
continues, "normal brain tissue and tumor often look alike to the eye,
but having the volumetric stereotactic image before me extends my vision,
letting me 'see' the entire tumor inside and out. Most important, it lets
me know exactly where the tumor ends and the brain itself begins, allows
me to remove the whole tumor and nothing but the tumor." Throughout surgery, a "virtual reality" image of the brain is projected in front of the surgeon's eyes by a "heads-up" video display unit mounted on the operating microscope. "What I see through the microscope," says Dr. Kelly, "is not only the actual surgical field itself, but also the computer-generated rendition of what actually is there and what's below the surface. I can see where I am and where I'm going."
Using
the stored 3-D image on a computer screen, the surgical procedure can
be simulated beforehand, to identify the optimal approach. Before going
into the operating room, the surgeon can decide where to open the skull,
how large to make the craniotomy, and what essential tissue and blood
vessels to avoid. Because the hole in the skull, the path to the tumor,
and the excision are substantially smaller than in conventional neurosurgery,
injury to the brain is further minimized.Dr. Kelly and his colleagues have conducted a study of 1,165 patients at NYU Medical Center and Mayo Clinic who had computer-assisted stereotactic neurosurgery. "We found that the tumors were completely removed in more than 90 percent of the cases," Dr. Kelly points out, "and the surgical mortality rate was less than one percent."
|
||
|
|||
| ©
1998 Mount Sinai-NYU Medical Center Health Care Systems All rights
reserved. Unaut horized
use prohibited. The information contained on the Health Care Solutions web site is not a substitute for medical advice or treatment, and Mount Sinai-NYU recommends consultation with a health care professional. |
|||